AI test detects heart disease before symptoms present
Researchers are evaluating Cardisio, an AI tool that determines if patients have cardiovascular disease before they show symptoms.
Developed in Germany, Cardisio interprets heart activity using cloud-based artificial intelligence algorithms.
The 10-minute test utilises five electrodes (four on the chest and one on the back) to monitor heart activity, with the Cardisio test returning a green, amber or red score.
The technology measures the heart’s electrical activity in three dimensions rather than the traditional two-dimensional ECG, and uses AI to interpret the data. That includes measuring the rhythm, structure and perfusion of the heart muscle.
The £340,000 study, funded by the SBRI (Small Business Research Initiative) and Cardisio, aimed to assess if the test could identify asymptomatic cardiovascular disease, and determine if testing in a community rather than hospital setting could reduce health inequalities.
The test was used in three settings in ethnically-diverse areas of the West Midlands between August 2023 and February 2024. These were a GP surgery in Handsworth, a pharmacy near Dudley and a community health centre in Quinton, with asymptomatic individuals aged 18 and above considered to be at risk of cardiovascular disease.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Simulations show Optimal Design for Bladeless Wind Turbines
"an 80cm mast" Really? I'm short but that's only half my height! Do they mean 800cm?